Crossref journal-article
Elsevier BV
Journal of Infection (78)
Bibliography

Halstead, D. C., Abid, J., & Dowzicky, M. J. (2007). Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial. Journal of Infection, 55(1), 49–57.

Authors 3
  1. Diane C. Halstead (first)
  2. Joan Abid (additional)
  3. Michael J. Dowzicky (additional)
References 26 Referenced 40
  1. 10.1086/502306 / Infect Control Hosp Epidemiol / Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study by D'Agata (2004)
  2. 10.1086/430314 / Clin Infect Dis / The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital by Pop-Vicas (2005)
  3. 10.1086/499406 / Clin Infect Dis / The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs by Cosgrove (2006)
  4. 10.1001/archinte.162.2.185 / Arch Intern Med / Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species by Cosgrove (2002)
  5. 10.1086/432940 / Clin Infect Dis / Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy by Lautenbach (2005)
  6. 10.1001/archinte.165.12.1375 / Arch Intern Med / Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: variability by site of infection by Hyle (2005)
  7. 10.1128/AAC.43.4.738 / Antimicrob Agents Chemother / In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936) by Petersen (1999)
  8. 10.1086/431672 / Clin Infect Dis / Tigecycline: a new glycylcycline for treatment of serious infections by Noskin (2005)
  9. {'key': '10.1016/j.jinf.2006.11.018_bib9', 'series-title': 'Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, document M7-A6', 'author': 'National Committee for Clinical Laboratory Standards', 'year': '2003'} / Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, document M7-A6 by National Committee for Clinical Laboratory Standards (2003)
  10. {'key': '10.1016/j.jinf.2006.11.018_bib10', 'series-title': 'Performance standard for antimicrobial susceptibility testing, document M100-S16', 'author': 'Clinical and Laboratory Standards Institute', 'year': '2006'} / Performance standard for antimicrobial susceptibility testing, document M100-S16 by Clinical and Laboratory Standards Institute (2006)
  11. {'key': '10.1016/j.jinf.2006.11.018_bib11', 'series-title': 'Tygacil product insert', 'author': 'Wyeth Pharmaceuticals', 'year': '2005'} / Tygacil product insert by Wyeth Pharmaceuticals (2005)
  12. 10.1345/aph.1D592 / Ann Pharmacother / Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians by Jain (2004)
  13. 10.1016/j.diagmicrobio.2004.02.003 / Diag Microbiol Infect Dis / Antimicrobial resistance rates and clonality results from the meropenem yearly susceptibility test information collection (MYSTIC) programme: report of year five (2003) by Rhomberg (2004)
  14. 10.1001/archinte.162.13.1515 / Arch Intern Med / Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has arrived by Landman (2002)
  15. 10.1016/j.diagmicrobio.2005.05.005 / Diag Microbiol Infect Dis / Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents by Sader (2005)
  16. 10.1016/j.diagmicrobio.2005.05.003 / Diag Microbiol Infect Dis / Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000–2004) by Fritsche (2005)
  17. 10.1086/431673 / Clin Infect Dis / In vitro activity of tigecycline against isolates from patients enrolled in Phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections by Bradford (2005)
  18. {'key': '10.1016/j.jinf.2006.11.018_bib18', 'first-page': '1063', 'article-title': 'Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2004', 'volume': '53', 'author': 'Centers for Disease Control and Prevention (CDC)', 'year': '2004', 'journal-title': 'MMWR Morb Mortal Wkly Rep'} / MMWR Morb Mortal Wkly Rep / Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2004 by Centers for Disease Control and Prevention (CDC) (2004)
  19. 10.3201/1108.050103 / Emerg Infect Dis / Multidrug-resistant Acinetobacter extremity infection in soldiers by Davis (2005)
  20. 10.1128/AAC.47.5.1681-1688.2003 / Antimicrob Agents Chemother / Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998–2001 by Karlowsky (2003)
  21. 10.1086/319757 / Clin Infect Dis / Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes by Lautenbach (2001)
  22. 10.1001/archinte.165.12.1430 / Arch Intern Med / Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City. A new threat to our antibiotic armamentarium by Bratu (2005)
  23. 10.1128/AAC.49.7.3018-3020.2005 / Antimicrob Agents Chemother / Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection by Bratu (2005)
  24. 10.1093/jac/dki175 / J Antimicrob Chemother / Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents by Bratu (2005)
  25. 10.1128/AAC.47.5.1672-1680.2003 / Antimicrob Agents Chemother / Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001 by Karlowsky (2003)
  26. 10.1128/JCM.42.1.1-6.2004 / J Clin Microbiol / Reality of developing a community-wide antibiogram by Halstead (2004)
Dates
Type When
Created 18 years, 7 months ago (Jan. 24, 2007, 7:12 a.m.)
Deposited 6 years, 4 months ago (April 23, 2019, 7:44 p.m.)
Indexed 28 minutes ago (Aug. 27, 2025, 4:22 p.m.)
Issued 18 years, 1 month ago (July 1, 2007)
Published 18 years, 1 month ago (July 1, 2007)
Published Print 18 years, 1 month ago (July 1, 2007)
Funders 0

None

@article{Halstead_2007, title={Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial}, volume={55}, ISSN={0163-4453}, url={http://dx.doi.org/10.1016/j.jinf.2006.11.018}, DOI={10.1016/j.jinf.2006.11.018}, number={1}, journal={Journal of Infection}, publisher={Elsevier BV}, author={Halstead, Diane C. and Abid, Joan and Dowzicky, Michael J.}, year={2007}, month=jul, pages={49–57} }